Risk Factors for Hepatotoxicity in HIV-Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine.

Autor: Gisolf, E. H., Dreezen, C., Danner, S. A., Weel, J.L.F., Weverling, G. J., Mayer, Kenneth H.
Předmět:
Zdroj: Clinical Infectious Diseases; 11/1/2000, Vol. 31 Issue 5, p1234-1239, 6p
Abstrakt: Presents a study that described hepatotoxicity in HIV-infected patients treated with ritonavir and saquinavir with or without stavudine. Information on liver enzyme elevation (LEE); Risk factors for LEE; Clinical management of the patients and the patients' outcome; Side effect of antiretroviral therapy.
Databáze: Complementary Index